Last Updated 5/20/2015
latest news The Silver Book: Cancer Briefing and Luncheon

On May 21st, join the Alliance for Aging Research, in partnership with the Personalized Medicine Coalition and American Association for Cancer Research, as we discuss the latest volume and policy factsheet from the Alliance's Silver Book®: Chronic Disease and Medical Innovation in an Aging Nation series, which shines the spotlight on the human and economic burden of cancer and explores the value of innovation—particularly personalized medicine and immuno-oncology—in reducing those burdens.
Read More >>

Visit Our News Archive

additional categories All the stats on Cancer, all in one place.


Cancer (PDF )

bullettView All Silver Book Volumes

horz rule

horz rule

most recent facts

Between August 2004 and July 2014, the FDA approved:
o 6 new anticancer therapeutics
o 5 new uses for previously approved anticancer therape [Permalink]

A 1 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and incr [Permalink]

Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicine [Permalink]

horz rule

Subscribe to our RSS Feed for all of the latest information on The Silver Book. To narrow your feed, subscribe from the page with the specific facts you're interested in.

The Silver Book® is an almanac of thousands of facts, statistics, graphs, and data from hundreds of agencies, organizations, and experts. It is a searchable database, produced and updated by the Alliance for Aging Research, that provides free and easy access to the latest information on the burden of chronic diseases that disproportionately impact older Americans, and the value of investing in medical research.

Use our Advanced Search to narrow and sort your results by Source, Category, and Date.

We hope that you find The Silver Book® to be a helpful resource and encourage you to check back regularly for new information. You can also receive e-mails on new volumes, events, and other Silver Book news by signing up for our E-Alerts

Sources by disease 2,181 facts currently online
cancer    

Around 2.6 million Americans are diagnosed with cancer each year, but thanks to major advances, close to 12 million Americans are cancer survivors. Get more facts.
 

Despite recent gains in reducing mortality, the burden of CVD continues to grow and the lifetime risk at age 40 of developing CVD is 2 in 3 for men and 1 in 2 for women. Get more facts.
 

People with diabetes have an increased risk of heart disease, stroke, kidney disease, vision loss, neurological damage, and lower limb amputations. Get more facts.
 
CardiovascularDisease
Stroke
Thrombosis
 
  spacer   spacer  
   

Every year, between 50,000 and 90,000 adults in the U.S. die from vaccine-preventable infectious diseases or their complications. Many serious infectious are acquired in the healthcare setting and those healthcare-associated infections cost U.S. hospitals between $28.4 and $45 billion each year. Get More Facts.
 

The prevalence of diseases like Alzheimer's and Parkinson's are skyrocketing as our population ages and they threaten to bankrupt our economy if better treatments and cures aren't found. Get more facts.
 

Like all of these diseases, osteoporosis impacts older Americans. It can lead to pain, disability, loss of independence, and even death. Get more facts.
Healthcare-Associated Infections
InfectiousDiseases
Vaccinations
 
NeurologicalDisease
Alzheimer'sDisease
Parkinson'sDisease
 
  spacer   spacer  
   

Around 100 million Americans live with persistent pain--more Americans than are affected by diabetes, heart disease, and cancer combined. Get More Facts. Get More Facts.
 

More than 38 million Americans age 40 and older are blind, visually impaired, or have an age-related eye disease, and adult vision loss costs our economy more than $5.1 billion each year. Get more facts.
 

1 in 4 Americans have more than one chronic disease—a major cost to our economy of 16% of GDP and growing. Without significant changes, the cost is projected to skyrocket to $4.3 trillion in 2017.